Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Oct;44(10):826-30.
doi: 10.1136/jcp.44.10.826.

Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic

Affiliations

Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic

L Agatensi et al. J Clin Pathol. 1991 Oct.

Abstract

Non-pregnant, non-diabetic outpatients were examined for the presence of pathogenic vaginal yeasts to determine if a correlation existed between a specific yeast and clinical disease. Yeasts were isolated as single vaginal species from 186 of 228 subjects with clinically diagnosed candidal vaginitis, as well as from 122 out of 380 asymptomatic, age-matched controls. Apart from Candida albicans and C glabrata, other prevalent species were C krusei, C parapsilosis and Saccharomyces cerevisiae which accounted for 9.2%, 6.0% and 5.4%, and 9.0%, 2.4% and 19.7%, of yeasts from patients and carriers, respectively. Only C albicans and C parapsilosis were significantly more common in those with vaginitis. Only the isolates of these two species secreted aspartyl proteinase in vitro, and the amount of the enzymes secreted by the isolates from patients was significantly higher than that secreted by the isolates from carriers. These two species consistently produced vaginal infection in pseudoestrus rats, whereas none of the non-proteolytic species tested (C glabrata, C krusei, and S cerevisiae) colonised the vagina in these rats. Proteinase secretion correlated with experimental vaginal infection; it could also be a reliable factor for distinguishing clinically active infection from asymptomatic fungal carriage.

PubMed Disclaimer

References

    1. JAMA. 1984 Feb 3;251(5):620-5 - PubMed
    1. Infect Immun. 1984 Jun;44(3):576-80 - PubMed
    1. Sabouraudia. 1984;22(3):175-83 - PubMed
    1. Am J Obstet Gynecol. 1985 Aug 1;152(7 Pt 2):921-3 - PubMed
    1. Am J Obstet Gynecol. 1985 Aug 1;152(7 Pt 2):924-35 - PubMed

Publication types

Substances

LinkOut - more resources